Recent studies have found that both killer-cell granzyme B and caspase-3 use cleavage at D270 to activate GSDME, induce tumor cells pyroptosis, enhance anti-tumor immunity, and exert tumor suppression effects. This evidence concerns the gene CASP3 and neoplasm.